case reports aspiration glp-1 receptor agonist anesthesia 2023 Glucagon-like peptide-1 agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system FLOW - The First Options:6 Bottles Metabolic Signaling

case reports aspiration glp-1 receptor agonist anesthesia 2023 Glucagon-like peptide-1 agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system FLOW - The First Options:6 Bottles Metabolic Signaling

FLOW - The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor Agonist

Liraglutide potentiated learning and memory performance, as well as eased anxiety levels in alcohol withdrawal mice

Metabolic Signaling

Options:6 Bottles

We have noticed a similar upward trend in utilization and spend for GLP-1s across our book of business, with plan drug spend for Wegovy alone increasing over 500% between 2022 and 2023